Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces its participation in the BioStock Life Science Summit, set to take place in Lund, Sweden, on November 20-21, 2024. The company will present at 1:30 pm on Wednesday the 20th of November.

For more information about BioStock Life Science Summit 2024, please visit BioStock Life Science Summit 2024 web page.

For further information, please contact:

Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49

catharina.svanborg@hamletpharma.com

Martin Erixon, CEO Hamlet BioPharma, +46-733 00 43 77

martin.erixon@hamletpharma.com

www.hamletbiopharma.com